Forest Laboratories, LLC

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 425 105 pages Agreement and Plan of Merger Dated as of April 27, 2014 by and Among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 105 pages Agreement and Plan of Merger Dated as of April 27, 2014 by and Among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc
12/34/56
EX-2.1
from 8-K 105 pages Agreement and Plan of Merger Dated as of April 27, 2014 by and Among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc
12/34/56
EX-2.1
from DEFA14A 105 pages Agreement and Plan of Merger Dated as of April 27, 2014 by and Among Forest Laboratories, Inc., Royal Empress, Inc. and Furiex Pharmaceuticals, Inc
12/34/56
EX-2.1
from 425 106 pages Agreement and Plan of Merger by and Among Actavis PLC, Tango US Holdings Inc., Tango Merger Sub 1 LLC, Tango Merger Sub 2 LLC and Forest Laboratories, Inc. Dated as of February 17, 2014
12/34/56
EX-2.1
from 8-K 106 pages Agreement and Plan of Merger by and Among Actavis PLC, Tango US Holdings Inc., Tango Merger Sub 1 LLC, Tango Merger Sub 2 LLC and Forest Laboratories, Inc. Dated as of February 17, 2014
12/34/56
EX-2.1
from 8-K 87 pages Agreement and Plan of Merger by and Among Frx Churchill Holdings, Inc., Frx Churchill Sub, Inc., Forest Laboratories, Inc., and Aptalis Holdings Inc. Dated as of January 7, 2014
12/34/56
EX-2
from SC 13D/A 5 pages Confidentiality Agreement
12/34/56
EX-2
from SC 13D/A ~1 page Amendment Number 1
12/34/56
EX-2
from SC 13D ~20 pages Notification Letter
12/34/56
EX-2.1
from 8-K 3 pages Amendment No. 1, Dated as of April 4, 2011 (This “Amendment”), to the Merger Agreement Referred to Below, Among Fl Holding CV, an Entity Organized Under the Laws of the Netherlands (“Parent”), Magnolia Acquisition Corp., a Delaware Corporation and an Indirect Wholly Owned Subsidiary of Parent (“Purchaser”), Forest Laboratories, Inc., a Delaware Corporation and the Indirect Parent of Parent (The “Guarantor”) and Clinical Data, Inc., a Delaware Corporation (The “Company”)
12/34/56
EX-2.1
from DEFA14A 3 pages Amendment No. 1, Dated as of April 4, 2011 (This “Amendment”), to the Merger Agreement Referred to Below, Among Fl Holding CV, an Entity Organized Under the Laws of the Netherlands (“Parent”), Magnolia Acquisition Corp., a Delaware Corporation and an Indirect Wholly Owned Subsidiary of Parent (“Purchaser”), Forest Laboratories, Inc., a Delaware Corporation and the Indirect Parent of Parent (The “Guarantor”) and Clinical Data, Inc., a Delaware Corporation (The “Company”)
12/34/56
EX-2.1
from 8-K 109 pages Agreement and Plan of Merger Among Fl Holding CV, Magnolia Acquisition Corp., Forest Laboratories, Inc. and Clinical Data, Inc. Dated as of February 22, 2011
12/34/56
EX-2
from 8-K ~10 pages Employment Agreement
12/34/56
EX-2
from SC 13G 1 page Id and Classification of Subsidiary
12/34/56